Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 32 min ago
Peer-reviewedCC BY 4.0Frontiers in Endocrinology

Diabetes mellitus and atrophic gastritis: progress in the study of interactive pathogenesis

3 more authors
  1. 1Changchun University of Chinese Medicine
  2. 2The Affiliated Hospital of Changchun University of Chinese Medicine
  3. 3Changchun Traditional Chinese Medicine Hospital

Abstract

Diabetes mellitus and atrophic gastritis are two chronic diseases with high incidence, and their comorbidity has attracted increasing attention. The traditional view primarily focuses on the unidirectional damage caused by diabetes to the gastric mucosa, but ignores the possible bidirectional pathological relationship between the two diseases. This article reviews research progress on the reciprocal pathogenesis between DM and the gastric mucosa and posits a theoretical framework of a “bidirectional vicious cycle.” On the one hand, diabetes may promote the occurrence and development of atrophic gastritis through multiple pathways. On the other hand, atrophic gastritis may have a profound reverse effect on glucose metabolism. The “common soil” for the coexistence of the two diseases is also revealed, including shared HLA class II susceptibility genes, Th17/Treg immune imbalance, and ROS-NF-κB-mitophagy disorders coupled with a molecular network. It should be noted that most of the proposed bidirectional framework is based on accumulating preclinical and observational evidence, and large-scale prospective cohort studies are urgently needed to establish causal temporal relationships. Based on the above mechanisms, this paper presents antioxidant-related intervention strategies and identifies the current study’s limitations. The purpose of this review is to promote the new clinical concept of “glucose-gastrotube co-administration” and provide a theoretical basis for breaking the mutually reinforcing cycle between the two diseases and reducing the risk of decompensation in gastric precancerous lesions and diabetes.

Related

  1. Marked Hypergastrinemia and Extreme Erythrocyte Sedimentation Rate Elevation in Autoimmune Atrophic Gastritis with Severe Iron Deficiency Anemia: A Case Report
    Hatem Mousa Taha, Khaled Hatem Taha
    Clinical case reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. The Bidirectional Relationship Between Tuberculosis and Type 2 Diabetes Mellitus: Pathogenesis, Treatment Challenges, and Prevention Strategies
    Archana Banda, Kim Pedrigal, Savannah Jayne +1
    CureusPeer-reviewedCC BYFull textEpidemiology & public healthInfectious diseaseEurope PMCPMC
  3. Lipoprotein(a), smoking, and diabetes are additive but not interactive risk factors for major adverse cardiovascular events after acute coronary syndrome
    Gregory G. Schwartz, Michael Szarek, Vera A. Bittner +11
    American journal of preventive cardiologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. From Genes to Diets: A Critical Review of Genetic, Nutrigenomic and Epigenetic Mechanisms in Type 2 Diabetes Mellitus
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  5. Incidence of diabetes remission and association with microvascular and macrovascular complications in patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study using real-world data in Thailand.
    Atittaya Janram, Ornanong Chanajarunwit, Thunyarat Anothaisintawee +4
    BMJ openPeer-reviewedCC BY-NCFull textEndocrinology & metabolismEurope PMCCrossref
BibTeX
@article{zhu2026diabetes,
  title = {{Diabetes mellitus and atrophic gastritis: progress in the study of interactive pathogenesis}},
  author = {Zexin Zhu and Ling Wang and Tingting Zhou and Yi Che and Ye Shi and Jiamei Song and Ziyu Zhang and Jian Xu and Shunyuan Tian and Ning Qu and Yihan Lu and Yuxin Hao and Jingzhou Zhang and Hongfei Gao and Guangfu Lv},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  month = oct,
  doi = {10.3389/fendo.2026.1955709},
  url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1955709/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Diabetes mellitus and atrophic gastritis: progress in the study of interactive pathogenesis
AU  - Zexin Zhu
AU  - Ling Wang
AU  - Tingting Zhou
AU  - Yi Che
AU  - Ye Shi
AU  - Jiamei Song
AU  - Ziyu Zhang
AU  - Jian Xu
AU  - Shunyuan Tian
AU  - Ning Qu
AU  - Yihan Lu
AU  - Yuxin Hao
AU  - Jingzhou Zhang
AU  - Hongfei Gao
AU  - Guangfu Lv
PY  - 2026
DA  - 2026/10/21
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1955709
UR  - https://www.frontiersin.org/articles/10.3389/fendo.2026.1955709/full
AB  - Diabetes mellitus and atrophic gastritis are two chronic diseases with high incidence, and their comorbidity has attracted increasing attention. The traditional view primarily focuses on the unidirectional damage caused by diabetes to the gastric mucosa, but ignores the possible bidirectional pathological relationship between the two diseases. This article reviews research progress on the reciprocal pathogenesis between DM and the gastric mucosa and posits a theoretical framework of a “bidirectional vicious cycle.” On the one hand, diabetes may promote the occurrence and development of atrophic gastritis through multiple pathways. On the other hand, atrophic gastritis may have a profound reverse effect on glucose metabolism. The “common soil” for the coexistence of the two diseases is also revealed, including shared HLA class II susceptibility genes, Th17/Treg immune imbalance, and ROS-NF-κB-mitophagy disorders coupled with a molecular network. It should be noted that most of the proposed bidirectional framework is based on accumulating preclinical and observational evidence, and large-scale prospective cohort studies are urgently needed to establish causal temporal relationships. Based on the above mechanisms, this paper presents antioxidant-related intervention strategies and identifies the current study’s limitations. The purpose of this review is to promote the new clinical concept of “glucose-gastrotube co-administration” and provide a theoretical basis for breaking the mutually reinforcing cycle between the two diseases and reducing the risk of decompensation in gastric precancerous lesions and diabetes.
SN  - 1664-2392
ER  -